The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 01, 2015
Filed:
Nov. 08, 2013
Applicant:
Signal Pharmaceuticals, Llc, San Diego, CA (US);
Inventors:
Sreenivas S. Bhat, Kendall Park, NJ (US);
Xiaozhong Liang, Edison, NJ (US);
Anthony Tutino, New Providence, NJ (US);
Anthony Joseph Frank, Easton, PA (US);
Assignee:
Signal Pharmaceuticals, LLC, San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/28 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/505 (2006.01); A61K 31/52 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2866 (2013.01); A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/485 (2013.01); A61K 9/4866 (2013.01); A61K 31/505 (2013.01); A61K 31/52 (2013.01);
Abstract
Provided herein are pharmaceutical formulations, comprising 4-((9-((3S)-tetrahydro-3-furanyl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2-yl)amino)-trans-cyclohexanol, including pharmaceutically acceptable salts, solvates, isomers, isotopologues, tautomers and racemic mixtures thereof, and a pharmaceutically acceptable excipient; and their use for treating or preventing disease.